The FY2025 (Dec) proxy of Kodiak Sciences names 17 peer companies for pay. Among Kodiak Sciences and these peers, CEO pay was 8th highest of 10 and total shareholder return was the highest of 10.
8th highest of 10in Kodiak Sciences and its pay peers, FY2025 (Dec) by CEO pay:
$2.1M$35.9M
1st highest of 10in Kodiak Sciences and its pay peers, FY2025 (Dec) by total shareholder return:
$9$391
Pay peer group, FY2025 (Dec) proxy
| Ocular Therapeutix | ||
| MeiraGTx Holdings | ||
| AbCellera Biologics | ||
| Nektar Therapeutics | ||
| Ocugen | ||
| Regenxbio | ||
| Annexon | ||
| Fate Therapeutics | ||
| 4D Molecular Therapeutics | ||
| Allogene Therapeutics | Not disclosed | Not disclosed |
| Coherus BioSciences | Not disclosed | Not disclosed |
| EyePoint Pharmaceuticals | Not disclosed | Not disclosed |
| Heron Therapeutics | Not disclosed | Not disclosed |
| Mersana Therapeutics | Not disclosed | Not disclosed |
| Prelude Therapeutics | Not disclosed | Not disclosed |
| RAPT Therapeutics | Not disclosed | Not disclosed |
| Viridian Therapeutics | Not disclosed | Not disclosed |
17 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.